Abstract
Autophagy is a relevant cellular defense mechanism that directly eliminates intracellular pathogens and has a crucial role for innate and adaptive immune responses. Some viruses have developed tools to counteract this cellular response. A179L, the viral Bcl2 homolog of African swine fever virus, interacts with proapoptotic Bcl2 family proteins to inhibit apoptosis. Here we report that this gene manipulates autophagy by interacting with Beclin 1 through its BH3 homology domain. At subcellular level, A179L colocalized with Beclin 1 at mitochondria and the endoplasmic reticulum. Virus infection inhibited autophagosome formation in cells; however, when autophagy was induced prior to or at the time of infection the number of infected cells was severely decreased.
Keywords: African swine fever virus, ASFV, autophagy, Beclin 1, BH3-only proteins, ER stress, viral Bcl2, viral Bcl2 homolog, autophagosomes, stress, starvation, homeostasis, hemorrhagic disease, pathogenesis, lymphoid hyperplasia.
Current Molecular Medicine
Title:A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein
Volume: 13 Issue: 2
Author(s): B. Hernaez, M. Cabezas, R. Munoz-Moreno, I. Galindo, M. A. Cuesta-Geijo and C. Alonso
Affiliation:
Keywords: African swine fever virus, ASFV, autophagy, Beclin 1, BH3-only proteins, ER stress, viral Bcl2, viral Bcl2 homolog, autophagosomes, stress, starvation, homeostasis, hemorrhagic disease, pathogenesis, lymphoid hyperplasia.
Abstract: Autophagy is a relevant cellular defense mechanism that directly eliminates intracellular pathogens and has a crucial role for innate and adaptive immune responses. Some viruses have developed tools to counteract this cellular response. A179L, the viral Bcl2 homolog of African swine fever virus, interacts with proapoptotic Bcl2 family proteins to inhibit apoptosis. Here we report that this gene manipulates autophagy by interacting with Beclin 1 through its BH3 homology domain. At subcellular level, A179L colocalized with Beclin 1 at mitochondria and the endoplasmic reticulum. Virus infection inhibited autophagosome formation in cells; however, when autophagy was induced prior to or at the time of infection the number of infected cells was severely decreased.
Export Options
About this article
Cite this article as:
Hernaez B., Cabezas M., Munoz-Moreno R., Galindo I., Cuesta-Geijo A. M. and Alonso C., A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein, Current Molecular Medicine 2013; 13 (2) . https://dx.doi.org/10.2174/15665240113130200007
DOI https://dx.doi.org/10.2174/15665240113130200007 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Engineered Biosynthesis of Medicinally Important Plant Natural Products in Microorganisms
Current Topics in Medicinal Chemistry Cinnamic Acid Derivatives as Anticancer Agents-A Review
Current Medicinal Chemistry Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action - Review
Current Medicinal Chemistry Nanoparticles in Melanoma
Current Medicinal Chemistry Liposome-Nanogel Structures for Future Pharmaceutical Applications
Current Pharmaceutical Design <i>In Silico</i> Approach to Predict the SARS-COV2 Derived Candidate MiRNAs as a Potential Antiviral Therapy
Current Drug Therapy NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Anti-Cancer Agents in Medicinal Chemistry Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
Current Medicinal Chemistry Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Exploiting EPR in Polymer Drug Conjugate Delivery for Tumor Targeting
Current Pharmaceutical Design Lifestyle Factors and MicroRNAs: A New Paradigm in Cancer Chemoprevention
MicroRNA On The Edge of Validation – Cancer Protease Fibroblast Activation Protein
Mini-Reviews in Medicinal Chemistry Clinical Aspects of Tumor Necrosis Factor-α Signaling in Hepatocellular Carcinoma
Current Pharmaceutical Design Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Current Molecular Pharmacology Biomarkers and Osteosarcoma and IGF
Recent Patents on Biomarkers Virally Encoded Polymerases as Targets for Chemotherapy: Application to HIV and HBV
Current Medicinal Chemistry - Anti-Infective Agents Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Current Medicinal Chemistry Subject Index To Volume 7
Current Drug Targets